February 21, 2019 / 11:57 AM / 3 months ago

Merck to buy cancer drug developer Immune Design for $300 mln

Feb 21 (Reuters) - U.S. drugmaker Merck & Co Inc said on Thursday it would buy immunotherapy developer Immune Design Corp for nearly $300 million to gain access to new cancer treatments.

Merck will pay $5.85 in cash for each share of Immune Design. Shares of Immune Design closed at $1.42 on Wednesday. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below